Medical Innovation

Følg

The Gregorio Marañón University Hospital has successfully performed Europe's first partial heart transplant on a seven-month-old baby. Mariami is recovering well after leaving Intensive Care just two days post-surgery. This breakthrough, endorsed by transplant authorities, combines pioneering techniques and could transform treatments for children with heart defects.

Rapportert av AI

Scientists at the Hebrew University of Jerusalem have developed a new drug molecule that specifically destroys TERRA, an RNA essential for some cancer cells' survival. Using a technique called RIBOTAC, the drug identifies and breaks down this RNA without harming healthy cells. Tests in cancer cell lines showed reduced growth, suggesting potential for novel therapies.

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis